Mostrar el registro sencillo

dc.contributor.authorSantibáñez Margüello, Miguel es_ES
dc.contributor.authorGarrastazu, Robertoes_ES
dc.contributor.authorRuiz Núñez, Marioes_ES
dc.contributor.authorHelguera, José Manueles_ES
dc.contributor.authorArenal, Sandraes_ES
dc.contributor.authorBonnardeux, Cristinaes_ES
dc.contributor.authorLeón, Carloses_ES
dc.contributor.authorGarcía Rivero, Juan Luises_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2017-07-03T10:51:43Z
dc.date.available2017-07-03T10:51:43Z
dc.date.issued2016es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.urihttp://hdl.handle.net/10902/11322
dc.description.abstractBackground and Aim Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs?particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients. Methods This was a retrospective population-based cohort study.We selected 900 patients with confirmed COPD aged 35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission.We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1?4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year. Results Of the patients, 16.4%had 1 severe exacerbations, varying from 9.3%in mild GOLD grade 1 to 44%in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95%confidence interval [CI], 3.53?12.83) and mortality (adjusted OR, 7.63; 95%CI, 3.41?17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated. Conclusions Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.es_ES
dc.format.extent13 p.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourcePLoS One. 2016;11(6):e0158727es_ES
dc.titlePredictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1371/journal.pone.0158727es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Atribución 3.0 EspañaExcepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España